Infant mortality (including stillbirths) and risk of death to the age of 15 months. Ditrame ANRS 049b trial. Abidjan, Côte d’Ivoire and Bobo-Dioulasso, Burkina Faso, 1996–8
| Time point | Day 0 (stillbirths) | 1 week (early neonatal mortality) | 1 month (neonatal mortality) | 1 year (infant mortality) | 15 months |
|---|---|---|---|---|---|
| *Calculated by Kaplan-Meier method. | |||||
| Number of birth outcomes: n = 55 in benzalkonium chloride group; n = 56 in placebo group. | |||||
| Cumulative number of deaths | |||||
| Benzalkonium chloride group | 2 | 4 | 4 | 11 | 12 |
| Placebo group | 3 | 3 | 3 | 9 | 9 |
| Likelihood of dying (%)* | |||||
| Benzalkonium chloride group* | – | 5.5 (1.8 to 16.0) | 7.3 (2.9 to 18.3) | 20.8 (12.1 to 34.4) | 22.9 (13.7 to 36.9) |
| Placebo group* | – | 5.4 (1.8 to 15.7) | 5.4 (1.8 to 15.7) | 16.5 (9.0 to 29.4) | 16.5 (9.0 to 29.4) |